Immunex logo — Pioneering therapeutic advancements for cancer, infectious d...

Immunex

Pioneering therapeutic advancements for cancer, infectious diseases, and autoimmune disorders

Founded 1981 Venture round Biotechnology, Health Care +1

General Information

Company Name Immunex
Founded Year 1981
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Immunex. To contact Immunex, visit immunex.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Immunex compare?

A PDF of Immunex and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Immunex soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Immunex

Immunex Corporation, founded in 1981 and based in Seattle, Washington, specializes in the development, manufacturing, and marketing of therapeutic products targeting cancer, infectious diseases, and autoimmune disorders. The company's slogan "Pioneering therapeutic advancements for cancer, infectious diseases, and autoimmune disorders" reflects its commitment to innovation in the Biotechnology, Health Care, and Manufacturing industries. With key products including Enbrel for rheumatoid arthritis, Novantrone for leukemia and prostate cancer-associated pain, and Leukine for bone marrow transplant patients, Immunex has established a strong presence in the market. Notably, the company received a Venture Round investment from New Enterprise Associates in January 1992. The strategic alliance with American Home Products further underscores Immunex's potential for growth and expansion. It's worth mentioning that as of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc. This acquisition signifies the recognition of Immunex's value and potential for long-term success in the industry.

Business keywords: Therapeutic Products, Cancer Treatment, Infectious Diseases, Autoimmune Disorders, Enbrel, Novantrone, Leukine, Research and Development, Acquisition, Strategic Alliance, Franchise Operations, Amgen, Seattle, Washington

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
New Enterprise Associates
01 Jan 1992

Immunex Alternatives & Competitors

View All Alternatives
Immunex vs

Pioneering treatments for kidney failure, renal disorders, and gastrointestinal diseases.

Venture round
1 employees
Biotechnology, Health Care
Immunex vs

We are advancing novel antigen modulation technology that controls T cells to guide the immune syste...

Series B
49 employees
Biotechnology, Health Care
Immunex vs

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Post-IPO Equity
Biotechnology, Health Care

FAQ About Immunex

Pioneering therapeutic advancements for cancer, infectious diseases, and autoimmune disorders
Immunex was founded in 1981.
Immunex operates in Biotechnology, Health Care and Manufacturing. Its work centres on Therapeutic Products, Cancer Treatment, Infectious Diseases and Autoimmune Disorders.
Immunex has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Immunex include NephRx Corporation, Greywolf Therapeutics, Anthera Pharmaceuticals, MacroGenics, Inc., Immunaeon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunex and NephRx Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Immunex, https://bouncewatch.com/company/immunex, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes